Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022

SELL
$6.72 - $16.07 $331,296 - $792,251
-49,300 Reduced 70.94%
20,200 $181,000
Q1 2022

May 11, 2022

SELL
$11.88 - $23.4 $2,376 - $4,680
-200 Reduced 0.29%
69,500 $1.06 Million
Q4 2021

Feb 11, 2022

SELL
$21.08 - $38.51 $57,759 - $105,517
-2,740 Reduced 3.78%
69,700 $1.59 Million
Q3 2021

Nov 12, 2021

SELL
$27.67 - $45.04 $8,301 - $13,512
-300 Reduced 0.41%
72,440 $2.5 Million
Q2 2021

Aug 10, 2021

SELL
$28.75 - $56.92 $627,037 - $1.24 Million
-21,810 Reduced 23.07%
72,740 $2.38 Million
Q1 2021

May 14, 2021

BUY
$38.67 - $84.06 $690,259 - $1.5 Million
17,850 Added 23.27%
94,550 $4.73 Million
Q4 2020

Feb 08, 2021

BUY
$55.23 - $81.11 $4.24 Million - $6.22 Million
76,700 New
76,700 $4.31 Million

Others Institutions Holding SEER

About Seer, Inc.


  • Ticker SEER
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,566,500
  • Market Cap $142M
  • Description
  • Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the secrets of the proteome. It develops Proteograph Product Suite, an integrated solution that comprises consumables, an automation instrumentation, and software that allows researchers to conduct proteomic studies in therapeutic and diagnostic res...
More about SEER
Track This Portfolio

Track Primecap Management CO Portfolio

Follow Primecap Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Primecap Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Primecap Management CO with notifications on news.